Published in Biochim Biophys Acta on July 12, 1974
Conjugated polyene fatty acids as membrane probes: preliminary characterization. Proc Natl Acad Sci U S A (1975) 1.61
Focal erythrocyte membrane perturbations caused by nitroxide lipid analogues. Proc Natl Acad Sci U S A (1974) 0.96
Electron spin resonance studies of erythrocytes from patients with Duchenne muscular dystrophy. J Clin Invest (1978) 0.89
Variations on fibrinogen-erythrocyte interactions during cell aging. PLoS One (2011) 0.87
Erythrocyte membranes undergo cooperative, pH-sensitive state transitions in the physiological temperature range: evidence from Raman spectroscopy. Proc Natl Acad Sci U S A (1976) 0.86
Effects of quenching mechanism and type of quencher association on stern-volmer plots in compartmentalized systems. Biophys J (1986) 0.75
Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry (1971) 66.90
Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells. Biochim Biophys Acta (1971) 5.74
Disposition of the major proteins in the isolated erythrocyte membrane. Proteolytic dissection. Biochemistry (1971) 3.91
Protein conformations in cellular membranes. Proc Natl Acad Sci U S A (1966) 3.27
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol (2000) 3.04
Inside-out red cell membrane vesicles: preparation and purification. Science (1970) 2.61
Social class, coronary risk factors and undernutrition, a double burden of diseases, in women during transition, in five Indian cities. Int J Cardiol (1999) 2.04
Clinical pharmacokinetics of capecitabine. Clin Pharmacokinet (2001) 1.91
Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans. Antimicrob Agents Chemother (1984) 1.70
Cellular membranes and tumor behavior: a new hypothesis. Proc Natl Acad Sci U S A (1968) 1.62
Prevalence of coronary artery disease and coronary risk factors in rural and urban populations of north India. Eur Heart J (1997) 1.61
Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites. Clin Cancer Res (1999) 1.57
Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting. Bull World Health Organ (1982) 1.57
Isolation and characterization of lymphocyte plasma membranes. Biochim Biophys Acta (1972) 1.54
The dispositions of proteins in the plasma membranes of animal cells: analytical approaches using controlled peptidolysis and protein labels. Biochim Biophys Acta (1972) 1.52
A model for the behavior of vesicles in density gradients: implications for fractionation. Biochim Biophys Acta (1970) 1.52
Plasmodium knowlesi-induced antigens in membranes of parasitized rhesus monkey erythrocytes. Proc Natl Acad Sci U S A (1978) 1.46
Lipid protein interactions in cellular membranes. Fed Proc (1969) 1.42
Antigenic distinctions of glycoproteins in plasma and mitochondrial membranes of lymphoid cells neoplastically transformed by simian virus 40. Proc Natl Acad Sci U S A (1977) 1.41
A critical evaluation of plasma membrane fractionation. Biochim Biophys Acta (1973) 1.37
Temperature-induced variations in the surface topology of cultured lymphocytes are revealed by scanning electron microscopy. Proc Natl Acad Sci U S A (1973) 1.37
Physicochemical differences between fragments of plasma membrane and endoplasmic reticulum. J Cell Biol (1966) 1.25
Differential effects of temperature on the nuclear and plasma membranes of lymphoid cells. A study by freeze-etch electron microscopy. Biochim Biophys Acta (1974) 1.24
Application of laser Raman and infrared spectroscopy to the analysis of membrane structure. Biochim Biophys Acta (1979) 1.23
Isolation of lipid-free plasma membrane proteins by gel filtration on Sephadex LH-20 using 2-chloroethanol-water as solvent. Biochim Biophys Acta (1967) 1.22
Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients. Clin Cancer Res (1998) 1.21
Cardiac resuscitation with percutaneous cardiopulmonary support. Lancet (1992) 1.19
A new sensitive, rapid fluorescence technique for the determination of proteins in gel electrophoresis and in solution. Anal Biochem (1973) 1.17
Simian virus 40-specific proteins in the membranes of simian virus 40-transformed hamster and mouse cells. Proc Natl Acad Sci U S A (1977) 1.17
Infrared spectra of plasma membrane and endoplasmic reticulum of Ehrlich ascites carcinoma. Biochim Biophys Acta (1968) 1.14
Synthesis, anticonvulsant and toxicity screening of newer pyrimidine semicarbazone derivatives. Eur J Med Chem (2010) 1.12
Membranes of normal hamster lymphocytes and lymphoid cells neoplastically transformed by simian virus 40. II. Plasma membrane proteins analyzed by dodecyl sulfate-polyacrylamide gel electrophoresis and two-dimensional immune electrophoresis. J Natl Cancer Inst (1976) 1.12
Membranes of normal hamster lymphocytes and lymphoid cells neoplastically transformed by simian virus 40. I. High-yield purification of plasma membrane fragments. J Natl Cancer Inst (1976) 1.11
Two Plasmodium knowlesi-specific antigens on the surface of schizont-infected Rhesus monkey erythrocytes induce antibody production in immune hosts. J Exp Med (1979) 1.10
The action of melittin on phosphatide multibilayers as studied by infrared dichroism and spin labeling. A model approach to lipid-protein interactions. Biochim Biophys Acta (1974) 1.10
Immunochemical analyses of membrane-bound complement. Detection of the terminal complement complex and its similarity to "intrinsic" erythrocyte membrane proteins. Biochim Biophys Acta (1975) 1.10
A reevaluation of the status of cholesterol in erythrocytes infected by Plasmodium knowlesi and P. falciparum. Mol Biochem Parasitol (1984) 1.09
Variations of lipid-protein interactions in erythrocyte ghosts as a function of temperature and pH in physiological and non-physiological ranges. A study using a paramagnetic quenching of protein fluorescence by nitroxide lipid analogues. Biochim Biophys Acta (1975) 1.08
Balloon angioplasty of totally and subtotally occluded coronary arteries: results using the Hydrophillic Terumo Radifocus Guidewire M (glidewire) Cathet Cardiovasc Diagn (1993) 1.08
Effect of melittin on thermotropic lipid state transitions in phosphatidylcholine liposomes. Biochim Biophys Acta (1976) 1.07
The reaction of 1-dimethylaminonaphthalene-5-sulfonyl chloride (DANSC1) with erythrocyte membranes. A new look at "vectorial" membrane probes. Biochim Biophys Acta (1973) 1.07
Erythrocyte membrane alterations due to infection with Plasmodium berghei. Biochim Biophys Acta (1973) 1.06
STUDIES OF UNBOUND AMINO ACID DISTRIBUTIONS IN PLASMA, ERYTHROCYTES, LEUKOCYTES AND URINE OF NORMAL HUMAN SUBJECTS. J Clin Invest (1960) 1.06
Anti-hypertensive dose-response effects of nicardipine in stable essential hypertension. Br J Clin Pharmacol (1985) 1.06
Anomalous side chain amidation in plasma membrane proteins of simian virus 40-transformed lymphocytes indicated by isoelectric focussing and laser Raman spectroscopy. Biochem Biophys Res Commun (1975) 1.05
Structural effects of myelin proteolipid apoprotein on phospholipids: a Raman spectroscopic study. Biochemistry (1978) 1.02
Structural differences among phosphatidylcholine, phosphatidylethanolamine, and mixed phosphatidylcholine/phosphatidylethanolamine multilayers: an infrared absorption study. Arch Biochem Biophys (1978) 1.02
Photoactivated cross-linking of proteins within the erythrocyte membrane core. J Biol Chem (1976) 1.02
Interaction between erythrocyte membrane proteins and complement components. II. The identification and peptide composition of complement components C3 and C4 desorbed from erythrocyte membranes. Biochim Biophys Acta (1974) 1.02
Pharmacokinetics of carumonam in patients with renal insufficiency. Antimicrob Agents Chemother (1986) 1.01
Calcium transport of Plasmodium chabaudi-infected erythrocytes. J Cell Biol (1982) 1.00
Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients. Cancer Chemother Pharmacol (1999) 0.99
Determinants on surface proteins of Plasmodium knowlesi merozoites common to Plasmodium falciparum schizonts. J Exp Med (1980) 0.99
Prevalence of rotavirus diarrhea among outpatients and hospitalized patients: a comparison. Southeast Asian J Trop Med Public Health (2001) 0.99
N-terminal amino acid analysis reveal peptide heterogeneity in major electrophoretic protein components of erythrocyte ghosts. Biochim Biophys Acta (1973) 0.98
Interaction of concanavalin A with rabbit thymocyte plasma membranes. Distinction between low affinity assoication and positively cooperative binding mediated by a specific glycoprotein. Biochim Biophys Acta (1976) 0.97
Carotenoids as a Raman-active probes of erythrocyte membrane structure. Biochim Biophys Acta (1975) 0.97
Membrane potential of Plasmodium-infected erythrocytes. J Cell Biol (1982) 0.97
Focal erythrocyte membrane perturbations caused by nitroxide lipid analogues. Proc Natl Acad Sci U S A (1974) 0.96
Multiple thermotropic state transitions in erythrocyte membranes. A laser-Raman study of the CH-stretching and acoustical regions. Biochim Biophys Acta (1976) 0.96
Quantitative determination of soluble and membrane proteins through their native fluorescence. Naturwissenschaften (1971) 0.96
Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef. Chemotherapy (1987) 0.95
Generalized membrane defects in cancer. N Engl J Med (1969) 0.94
Pharmacokinetics and biliary concentrations of fleroxacin in cholecystectomized patients. Antimicrob Agents Chemother (1990) 0.94
Intercellular communication in cell-mediated cytotoxicity. Fluorescein transfer between H-2 d target cells and H-2 b lymphocytes in vitro. Eur J Immunol (1971) 0.94
High affinity calcium binding sites on erythrocyte membrane proteins. Use of lanthanides as fluorescent probes. Biochim Biophys Acta (1974) 0.93
Raman analysis of the thermotropic behavior of lecithin-fatty acid systems and of their interaction with proteolipid apoprotein. Biochemistry (1980) 0.93
The study of lipid-protein interactions in membranes by fluorescent probes. Biochim Biophys Acta (1970) 0.93
Protein conformational transitions in the erythrocyte membrane. Biochim Biophys Acta (1971) 0.93
Raman and infrared spectroscopic study of gramicidin A conformations. Arch Biochem Biophys (1980) 0.92
Isolation of plasma membrane vesicles from animal cells. Methods Cell Biol (1977) 0.92
Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease. Br J Clin Pharmacol (1984) 0.92
Fractionation of Plasmodium knowlesi-induced antigens of rhesus monkey erythrocyte membranes. Bull World Health Organ (1979) 0.92
Two-dimensional separation of erythrocyte membrane proteins. Biochim Biophys Acta (1975) 0.91
Membrane potential of erythrocytic stages of Plasmodium chabaudi free of the host cell membrane. Mol Biochem Parasitol (1986) 0.91
Energy-dependent protein conformational transitions in mitochondrial membranes. Biochim Biophys Acta (1969) 0.91
Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens. Vaccine (1996) 0.90
Effects of cholesterol on the infrared dichroism of phosphatide multibilayers. Biochim Biophys Acta (1973) 0.90
Biochemical and immunochemical characterization of two simian virus 40 (SV40)-specific glycoproteins in nuclear and surface membranes of SV40-transformed cells. Biochem Biophys Res Commun (1979) 0.90
Simian virus 40 (SV40)-specific isoelectric point-4.7--94,000-Mr membrane glycoprotein: major peptide homology exhibited with the nuclear and membrane-associated 94,000-Mr SV40 T-antigen in hamsters. J Natl Cancer Inst (1982) 0.90
Raman and resonance-Raman scattering by erythrocyte ghosts. Biochim Biophys Acta (1975) 0.89
Transformation by simian virus 40 induces virus-specific, related antigens in the surface membrane and nuclear envelope. Proc Natl Acad Sci U S A (1977) 0.89
Pharmacodynamic monitoring during acute intervention in ischaemic heart disease using a new echo-Doppler device. Br J Clin Pharmacol (1990) 0.89
Plasma concentrations of sulfadoxine in healthy and malaria infected Thai subjects. Acta Trop (1988) 0.89
Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects. Chemotherapy (1987) 0.89
The optical activity of plasma membranes and its modification by lysolecithin, phospholipase A and phospholipase C. Biochim Biophys Acta (1969) 0.88
Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients. Cancer Chemother Pharmacol (1999) 0.87